Silexion Therapeutics earnings
When SLXN reports, and what its stock did after each report.
Next report
Expected around mid February, going by its own filing history. The company has not announced a date yet.
Who else reports that week: the earnings calendar.
Last report: Nov 16, 2026, 06:01 ET (before the open). The filing on SEC EDGAR ↗
After each report
SEC EDGAR · 1D EODAcross the last 4 reports we hold closes for, the first close moved a median 7.01% either way. Up 1 of 4.
Moves are only shown for reports where we hold closing prices.
- Nov 16, 202606:01 ET · before the open8-K ↗−11.11%1DRevenue $18.00K−53.8% y/yEPS $13.70quarter to Sep 30, 2026
- Aug 14, 202609:00 ET · before the open8-K ↗−8.65%1DRevenue $14.00K−68.2% y/yEPS $5.17quarter to Jun 30, 2026
- May 18, 202608:33 ET · before the open8-K ↗−5.36%1DRevenue $32.00K+1500.0% y/yEPS $8.46quarter to Mar 31, 2026
- Nov 12, 202509:07 ET · before the open8-K ↗+3.56%1DRevenue $39.00KEPS $691.14quarter to Sep 30, 2025
- Before Sep 2, 2025 we don't hold closing prices, so these reports show the date and what was filed, without a move.
- Aug 12, 202508:31 ET · before the open8-K ↗Revenue $44.00K+633.3% y/yEPS $43.19quarter to Jun 30, 2025
- May 13, 202516:55 ET · after the close8-K ↗Revenue $2.00K−89.5% y/yEPS $38.39quarter to Mar 31, 2025
- Mar 18, 202516:42 ET · after the close8-K ↗Revenue $3.00Kquarter to Dec 31, 2024
- Jan 14, 202506:01 ET · before the open8-K ↗Revenue $3.00Kquarter to Dec 31, 2024
- Nov 14, 202409:03 ET · before the open8-K ↗Revenue $0.00KEPS $274.25quarter to Sep 30, 2024
Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. Prior-session closes only; not a forecast, not advice.